These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 20200933)
1. A patient with severe hypercalcemia in multiple organ dysfunction syndrome: role of elevated circulating 1alpha,25(OH)2 vitamin D levels. Kazama JJ; Yamamoto T; Oya H; Yamamoto S; Sato Y; Sakurada J; Honda T; Endoh H; Narita I J Bone Miner Res; 2010 Jun; 25(6):1455-9. PubMed ID: 20200933 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D. Falk S; Kratzsch J; Paschke R; Koch CA Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303 [TBL] [Abstract][Full Text] [Related]
5. [Circulating metabolites of vitamin D in 14 children with hypercalcemia]. Jacqz E; Garabedian M; Guillozo H; Bourdeau A; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S Arch Fr Pediatr; 1985 Mar; 42(3):225-30. PubMed ID: 3873927 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. Hewison M; Kantorovich V; Liker HR; Van Herle AJ; Cohan P; Zehnder D; Adams JS J Bone Miner Res; 2003 Mar; 18(3):579-82. PubMed ID: 12619944 [TBL] [Abstract][Full Text] [Related]
8. [The expression and clinical implication of advanced oxidized protein products in patients with multiple organ dysfunction syndrome]. Xiong Y; Tang H; Li X; Liang YB; Liao XX; Zhan H; Jing XL; Li YJ; Ma ZF Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Sep; 20(9):542-5. PubMed ID: 18786315 [TBL] [Abstract][Full Text] [Related]
9. Unusual cases of chronic intoxication by vitamin D. Chiricone D; De Santo NG; Cirillo M J Nephrol; 2003; 16(6):917-21. PubMed ID: 14736022 [TBL] [Abstract][Full Text] [Related]
10. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma. Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119 [TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide. Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119 [TBL] [Abstract][Full Text] [Related]
12. Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. Garabédian M; Jacqz E; Guillozo H; Grimberg R; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S N Engl J Med; 1985 Apr; 312(15):948-52. PubMed ID: 3838365 [TBL] [Abstract][Full Text] [Related]
13. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia. Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336 [TBL] [Abstract][Full Text] [Related]
14. Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer. Liu G; Oettel K; Ripple G; Staab MJ; Horvath D; Alberti D; Arzoomanian R; Marnocha R; Bruskewitz R; Mazess R; Bishop C; Bhattacharya A; Bailey H; Wilding G Clin Cancer Res; 2002 Sep; 8(9):2820-7. PubMed ID: 12231522 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D status of chronic kidney disease patients living in a sunny country. Cuppari L; Carvalho AB; Draibe SA J Ren Nutr; 2008 Sep; 18(5):408-14. PubMed ID: 18721735 [TBL] [Abstract][Full Text] [Related]
16. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835 [TBL] [Abstract][Full Text] [Related]
17. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811 [TBL] [Abstract][Full Text] [Related]
18. Late association of hyperparathyroidism in septic patients with multiple organ failure. Lucas CE; Ledgerwood AM; Jeffries CC; Vernier P Surgery; 2010 Jul; 148(1):135-9. PubMed ID: 20116815 [TBL] [Abstract][Full Text] [Related]
19. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis. Gates S; Shary J; Turner RT; Wallach S; Bell NH J Bone Miner Res; 1986 Apr; 1(2):221-6. PubMed ID: 3503540 [TBL] [Abstract][Full Text] [Related]
20. Life-threatening tertiary hyperparathyroidism in the critically ill. Jeffries CC; Ledgerwood AM; Lucas CE Am J Surg; 2005 Mar; 189(3):369-72. PubMed ID: 15792772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]